Bayer builds trust in AI agents through data-driven process transformation
PositiveArtificial Intelligence

Bayer AG's recent partnership with Celonis SE marks a pivotal moment in the integration of process intelligence and AI within the pharmaceutical and life science industries. By focusing on process mining and agentic AI, Bayer aims to navigate increasingly complex infrastructure requirements while fostering trust in AI agents. This initiative is part of a broader trend where businesses are transforming their operations through data-driven processes, highlighting the growing importance of technology in enhancing efficiency and reliability in critical sectors.
— via World Pulse Now AI Editorial System
